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1. INTRODUCTION 
 
  Sjögren`s syndrome (SS), rheumatoid arthritis (RA), and systemic 
lupus erythematosus (SLE) are members of the family of systemic autoimmune 
diseases, in which the immune response is activated to recognize a limited 
variety of ubiquitously expressed autoantigens, and during which several target 
tissues may become damaged.  
  Features of SS may be found in almost every autoimmune rheumatic 
disease, including RA, SLE, scleroderma and others. The development of 
secondary SS associated with RA occurs on a different genetic background 
(HLA-DR4). 
  Early diagnosis and appropriate treatment are essential for optimal 
management of SS, and affect the patients` general well being and quality of 
life. At present, there are no specific diagnostic tests for SS and no universally 
accepted diagnostic criteria. 
  Many outcome parameters have to be recorded in order to assess the 
response for the treatment in clinical studies of RA. Only few laboratory 
markers, such as C-reactive protein or erythrocyte sedimentation rate correlate 
well with the inflammatory activity of RA. Since both parameters are frequently 
elevated in case of other conditions e.g. infections, there is currently no 
surrogate marker that specifically reflects the degree of joint inflammation. This 
is of importance, since the interobserver variability in assessing the clinical 
status of RA patients can be considerable. 
  Most autoantibodies are not specific for SLE and might be produced 
non-specifically as a result of polyclonal B cell activation. An ideal test would 
be specific, sensitive and have a high positive predictive value, and it should 
reflect disease activity, correlate with organ involvement, or predict relapse. No 
test or test panel can currently perform all these tasks because some of the 
clinical features of SLE are not antibody mediated. 
  Lysosomal enzymes seem to play an important role in many 
physiological and pathological processes. Alterations in their activity have been 
observed in a great variety of disorders, like inflammation process or neoplasias. 
Previous studies have also demonstrated increased activities of lysosomal 
hydrolaseses in the serum of patients with RA, SLE, dermatomyositis or 
psoriasis. We measured the activity of lysosomal enzyme activities in patients 
with adenocarcinomas of the gastroesophageal junction and the squamous cell 
carcinomas of the lower third of the esophagus. Our results and other studies 
have called our attention to compare the progression of the well known 
ophthalmic observations in polysystemic diseases to the lysosomal enzyme 
activities in leukocytes which were used for the diagnosis of other type of 
diseases.     
1. 16.
2. CONCEPTUAL BACKGROUND 
 
2.1 Sjögren`s syndrome 
 Sjögren's syndrome (SS), one of the most common autoimmune 
diseases, is characterized by progressive lymphocytic and plasma cell infiltration 
of the salivary and lacrimal glands leading to xerostomia and xerophthalmia, 
respectively. Other tissues and organs may also be affected with multiple 
extraglandular manifestations such as arthritis, cutaneous vasculitis, renal 
tubular acidosis, and chronic pulmonary disease. The most common form of 
ocular involvement is immune mediated noninfectious inflammation of the 
lacrimal glands and ocular surface resulting in decreased tear production and 
inflammatory changes on the ocular surface, known as SS associated 
keratoconjunctivitis sicca (KCS). Some common signs of KCS are conjunctival 
injection, mucous strands, filamentary keratitis, tear film debris, and a punctate 
keratopathy. Advanced KCS may lead to serious complications, including 
keratitis, symblepharon, pannus, corneal thinning, and ceration with perforation. 
 
2.2 Rheumatoid arthritis 
 Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease 
primarily affecting the synovial membrane and leading to joint damage and joint 
destruction. Apart from the potentially destructive joint manifestations of the 
disease, it is also characterized by systemic features. Rheumatoid arthritis is 
associated with numerous ophthalmic signs and symptoms. The most significant 
complications include KCS, keratitis, sclerokeratitis, scleritis, scleromalacia 
perforance, and uveitis. Rapid detection and early treatment decreases the ocular 
complications and increases the overall quality of the life of patients. 
 
2.3 Systemic lupus erythematosus 
Systemic lupus erythematosus (SLE) is a chronic generalized inflammatory 
connective tissue disease with characteristic autoantibodies primarily affecting 
the skin, musculoskeletal system, serous membranes, kidneys, central nervous 
system (CNS), and cells of the blood. Acute exacerbations of disease activity are 
followed by periods of remission. About 80%-90% of SLE patients are women. 
KCS, with or without xerostomia and retinopathy are the most common ocular 
manifestations. Involving the retina, cotton-wool spots and retinal hemorrhages 
are the most frequently reported findings, but retinal edema, hard exudates, 
microaneurysms, and vascular tortuosity have also been noted. Lupus 
retinopathy can occur as an independent manifestation of the underlying disease 
process. Central retinal vein occlusion has also been reported in patients with 
SLE, but appears to be less common than arterial occlusive disease.  
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2.4   Lysosomal enzymes 
 Human polymorphonuclear leukocytes (PMNL) play a fundamental role 
in many inflammatory diseases. Their proinflammatory activity is exerted 
trough the release of different chemical mediators, such as preformed 
mediators, including several lysosomal enzymes and de novo synthesized 
mediators, like oxygen-free radicals. 
 Lysosomal enzymes are common in human body fluids, such as serum, 
urine, and tears. Some studies have also revealed the lysosomal enzyme 
activities in aqueous humor and subretinal fluid, but so far no study has 
investigated the specific activities of lysosomal enzymes from the leukocytes 
of patients with SS, RA, and SLE. 
  Specific activity of some lysosomal enzymes have been demonstrated in 
the anterior segment of the eye, in ciliary body, corneal epithelium, stormal 
keratocytes, endothelium, as well as lens epithelium. 
 
3. AIMS 
 
Based on previous studies, we hypothetized that 
- the lysosomal glycosidase and protease activities in leukocytes may  
provide information in the role of tissue damage by enzymes in 
polysystemic autoimmune disease, 
-  proteinases and glycosidases from leukocytes might represent potential 
markers of the disease activity.   
In order to get answer for the hypotheses above, patients with primary SS, RA, 
and SLE were chosen for our investigations. 
The aims of this study were: 
- the ophthalmic examinations of patients in the three groups of  
  autoimmune diseases and controls, 
- to measure the activities of lysosomal glycosidases and proteases in  
leukocytes of the patients in the three groups of autoimmune diseases and 
controls, 
- to find a potential correlation between the ophthalmic signs and activity  
values of lysosomal enzymes in patients of the three autoimmune 
diseases, 
- to determine whether activities of enzymes in leucocytes might be 
markers for monitoring the progression of SS, RA, and /or SLE. 
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4. PATIENTS AND METHODS 
 
4.1. Patients 
 Thirty-eight patients with primary SS (1 male, 37 female) with a mean 
age of 53 years; thirty persons (5 males and 25 females), mean age 56 years, 
who were registered as RA patients; thirty-seven SLE patients (1 male and 36 
females) with a mean age of 45 years, and 36 healthy subjects (12 males and 
24 females) with a mean age of 50 years were selected randomly for this 
study.  
 The control group was without any autoimmune or other documented 
disease. SS, RA and SLE patients were subdivided into 3 groups based on the 
duration of the illness: patients were diagnosed 1) less than 5 years, 2) 5-10 
years, and 3) more than 10 years prior to enrollment. In cases of SS, the first 
group had nine, the second group had seven, and the third group had twenty-
two patients. In cases of RA: fourteen, ten, and six patients were in the 1st, 2nd, 
and 3rd groups, respectively. Sixteen SLE patients were in the first, ten in the 
second, and eleven in the third group. 
 
4.2. Ophthalmic examinations  
Patients with SS, RA, and SLE and the control subjects underwent 
standard ophthalmologic examinations including visual acuity tests, 
intraocular pressure with applanation tonometer, slit-lamp biomicroscopic 
examination of the anterior segment of the eye using slit-lamps, and 
ophthalmoscopic examination with direct ophthalmoscope and 90 D lense. 
The patients` perimetry was carried out by TAP and Goldmann perimeter. 
Additionally, all subjects were evaluated for KCS using the Schirmer I test 
(without any anesthetics), break-up time test (BUT), and rose bengal score 
measurements. The ocular tests were considered positive as follows: wetting 
of ≤5 mm of the paper strip in 5 minutes on the Schirmer I test, BUT ≤10 
seconds, and rose bengal score of ≥4 on the von Bijsterweld scoring system. 
 
4.3. Sample preparation for enzymatic assay 
 Blood samples were taken using Vacutainer® cell preparation tubes 
containing sodium citrate. For leukocyte purification, a heparin-dextran 
solution was added to the blood according to Johnson et al.. After incubation 
at room temperature for 1–2 hours, the upper layer was removed and 
centrifuged at 870 x g for 10 minutes. The pellet was resuspended in 1 mL 
normal saline plus 3 mL distilled water and centrifuged at 515 x g for 8 
minutes. The pellet was free of red blood cells, and was resuspended in 4 mL 
normal saline and centrifuged at 515 x g for 8 minutes. After repetition of the 
last step, the leukocytes were homogenized in 0.15 M NaCl in 0.1% Triton-X 
100 with a “Brinkman” Polytron homogenizer. 
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8. SUMMARY AND CONCLUSIONS 
 
- Significantly increased lysosomal enzyme activities (proteases and 
glycosidases) were found in leukocytes from patients who had been 
suffering from SS for more than 5 years, but less than 10 years. 
 
- The changes in lysosomal enzyme activities indicate that these enzymes 
might play a role in SS-associated tissue injury. The activities of 
glycosidases, which are important in glycoprotein breakdown, and 
proteases, DPP I and TPP I, which play a role in proteolytic and in 
collagen degradation, were elevated. 
 
- In the latter stages of SS (>10 years), the presence of ophthalmic signs 
may be a consequence of the long-lasting tissue injury caused by 
elevated lysosomal enzymes.  
 
- We can conclude from our results that elevated levels of two 
glycosidases (AGU and HEX) and some lysosomal proteases (DPP I, 
CATH B and CATH D), but not TPP I or DPP II, are associated with 
RA. Lysosomal cysteine and aspartate peptidases may be responsible 
for the elevated level of protein destruction in RA.  
 
- All of the enzymes showed higher elevation among those RA patients 
who had keratitis, except for DPP I, CATH B and CATH D, while 
those patients who had any kind of corneal degeneration showed high 
elevation of CATH B. 
 
- Since CATH B showed the highest enzyme activity increase in the 
three groups of RA patients investigated, it may provide a reliable 
marker for monitoring the progression of RA. 
 
- In cases of patients with SLE, there were almost the same number of 
patients with atrophy of the optic nerve in the second (5-10 years) and 
in the third group (>10 years) and higher elevation of enzyme activities 
was found among these cases. All of the glycosidases and the proteases, 
but CATH H and CATH D show the progression of the disease. 
 
- We suggest that the measurement of lysosomal enzyme activities in 
leukocytes and ophtalmic observations will be of great value for further 
evaluation of these enzymes as a prognostic marker in polysystemic 
autoimmune diseases and tissue damage. 
 
The homogenized material was then centrifuged, and the supernatant was used 
for the enzyme assays and protein determination. 
 
4.4. Measurement of enzyme activities 
Glycosidase activities were measured with the use of 4-
methylumbelliferyl (4-MU) substrates. Protease assays with 7-amino-4-
methylcoumarin (AMC) substrates or FITC-hemoglobin were carried out as 
described previously. Samples of 5, 10 or 25 µL were diluted 2-, 4-, and 8-fold 
with 0.15 M NaCl-0.1% Triton-X 100. Duplicates from each dilution were 
transferred to 96-well microtiter plates. The enzyme reaction was initiated by 
addition of a solution containing a substrate in buffer, and the plates were 
incubated at 37 °C for 30–180 min. Assays involving 4-MU and AMC substrates 
were stopped by adding 100 µL 0.5 M glycine-NaOH buffer at pH 10.5, or 100 
µL 0.1 M monochloroacetic acid in 0.1 M acetic acid at pH 4.3. The amount of 
4-MU or AMC liberated at the assay is proportional to the enzyme activity; the 
unit for both assays is nmol/h/mg protein. The substrates were obtained from 
Sigma (St. Louis, MO, USA), except for the DPP I substrate (H-Gly-Arg-AMC) 
and the cathepsin L inhibitor (Z-Phe-Phe-diazomethylketone) for the CATH B 
assay, which were obtained from Bachem Bioscience Inc. (King of Prussia, PA, 
USA). 
The emission (λex 360 nm, λem 460 nm) was measured with a Cytofluor II, 
Fluorescence multi-well plate reader (CytoFluor 4000, PerSeptive Biosystems, 
Inc., Framingham, MA, USA). The activities were normalized to the protein 
content in the sample measured according to the method of Lowry et al.. 
 
4.5. Statistical analysis 
Data are presented as mean±SE. Statistical significance was assessed by 
the Student t test and the Kruskal-Wallis one-way ANOVA on ranks. The results 
were considered significant, if p < 0.05. 
 
4.6. Ethics 
This study was conducted in accordance with the Declaration of Helsinki. 
This medical research was subject to ethical standards that promote respect for 
all human beings and protect their health and rights. It conformed to generally 
accepted scientific principles based on a thorough knowledge of scientific 
literature, other relevant sources of information, and on adequate laboratory 
experimentation. The experimental protocol was approved by the ethical review 
committee of the University of Szeged. The right of research subjects to 
safeguard their integrity was always respected. 
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5. RESULTS 
 
5.1. Sjögren`s syndrome (SS) 
 
5.1.1 Ophthalmological signs of patients with SS 
 Filamentary keratitis (32%) and a decreased tear production (55%) 
were more marked in the third group of SS patients (who were sick for more 
10 years), than that of in the second group (5-10 years) with 14% and 29%, 
respectively. Cupping of the optic disc was only found in the third group (>10 
years). 
 We also found that all of the SS patients had KCS and one patient had 
conjunctival degeneration (pinguecula), too. The next observed 
ophthalmological signs did not differ with the duration of the disease: corneal 
degeneration (4 patients), cataract (4 patients), atrophy of the optic nerve (26 
patients), and visual field defects (12 patients). In two cases, we found 
maculopathy, and one patient exhibited macular degeneration.  
5.1.2 Lysosomal enzyme activities in leukocytes of patients with SS  
 In all the SS patients, significantly increased activities of the 
glycosidases BGA, AMAN, GCU, HEX; and the proteases CATH B, DPP I, 
TPP I, and CATH D were found as compared with the controls.  
 In the first group (SS was recognized less than 5 years prior to our 
investigations), the activities of BGA, AMAN, GCU, HEX, CATH B and 
DPP I were increased significantly as compared to the controls. In the second 
group (5-10 years of sickness), all of the measured lysosomal enzyme 
activities were elevated as compared both to the controls and to the first SS 
group, except for two enzymes: CATH B, which showed elevated values only 
when compared to the control group and AGU, which activity was not higher 
than that of the controls. In the third group (>10 years), the enzyme activities 
were less than in the second group, but the activities of AMAN, GCU, and 
HEX remained significantly elevated compared to the control values. 
5.1.3 Association between lysosomal enzyme activities and ophthalmologial 
signs of patients with SS 
 The Schirmer I test, performed according to precious studies was the 
most accurate among all of the published functional tests. Enzyme activities 
increased to a greater degree in subjects with SS whose Schirmer I test was >5 
mm in 5 min (n = 18) than in those patients whose Schirmer I test was ≤5 mm 
in 5 min (n = 20). DPP I, AMAN, GCU, and HEX activities were significantly 
increased in case of subjects whose tear production was ≤5 mm in 5 min, as 
compared to the control group. Direct correlation has been found between the 
activity of CATH B and D and the Schirmer I test (data not shown). 
Additional studies should be conducted to determine the reason for this 
relation.  
 
concluded in agreement with Florakis et al. that this symptom is not related to 
the age of the patients. 
 In every individual with RA, we found significant correlation between 
the presence of keratitis and elevation of specific activities of the measured 
glycosidases, but BGA and DPP II. On the other hand, CATH B also showed 
elevated activity, but the elevation did not correlate with the observed keratitis 
(Figure 5). CATH B and CATH D showed significant elevation among those 
patients who had any other kind of corneal degeneration. There were only three 
patients who had keratitis and also three who had corneal degeneration, so a 
study of larger populations is needed to confirm the prognostic importance and 
clinical relevance of this factor in RA. 
 KCS is the most common ocular manifestation of SLE, but visual 
morbidity is usually due to retinal and neuro-ophthalmic manifestations of the 
disease. Ocular manifestations of lupus are significant in that they reflect 
extraocular involvement of the disease. Their presence should alert the clinician 
to the likely presence of extraocular disease activity. Less patients had atrophy of 
the optic nerve (30%) in the third group (>10 years) than  in the second one (5-
10 years) (40%). All of the enzymes showed higher elevation among those 
patients who had optic nerve atrophy, except for CATH H and CATH D. This 
means, that all of the glycosidases and the proteases, but CATH H and CATH D 
could show the progression of the disease in case of SLE. 
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information about the role of these enzymes in the progress of the disease. AGU, 
AMAN, GCU, HEX (glycosidases), and CATH D showed moderate increase of 
the activity. In contrary, the elevation of DPP I and CATH B activity was much 
more emphasized. They were the highest in the group of patients that were sick 
more than 10 years. DPP II and TPP I and the cysteine protease CATH H activities 
did not change during the observation period, as we predicted by the substrate 
specificity.  
 In contrast to a previous study, our investigations demonstrated that in 
cases of patients with SLE, all of the lysosomal enzymes being investigated 
showed significant increase except for CATH H. BGA, CATH C, and DPP I. 
showed the highest enzyme activity increase in the second group, which was 
similar in case of SS patients. The elevation of enzyme level in cases of GCU and 
HEX was similar in the three groups of patients. TPP I, CATH B and CATH D 
had the highest enzyme activities in the first group of patients, who were 
diagnosed less than 5 years before the investigation. The other enzymes did not 
show any characteristic pattern. 
 
 6.3 Relation between ophthalmic findings and elevated lysosomal enzyme 
activities 
 The reduction in tear secretion noted in subjects with SS of >10 years’ 
duration was consistent with the aforementioned results, as the increased release of 
proteolytic and glycolytic enzymes in the lacrimal glands could cause degradation 
of the glandular extracellular matrix, thus leading to this effect  
 Filamentary keratitis, a severe ophthalmologic sign in SS patients, was 
also seen mostly in subjects with SS of >10 years’ duration. However, enzyme 
activities were higher among patients who did not have this ophthalmic disorder, 
except in the cases of AGU, CATH B, and CATH D (Figure 3). Thus, lysosomal 
enzyme activities in the leukocytes of subjects with SS appeared to follow the state 
of the disease in the first 10 years. The relatively lower elevations of activities in 
patients with SS of >10 years’ duration as compared to those who were sick for 5-
10 years were not indicative of recovery from the disease, as evidenced by the 
relatively higher incidence of keratitis in this group. Rather, it suggests that 
enzyme activity cannot increase any further because of the slower protein 
synthesis in this stage of the disease; a similar phenomenon is seen with late-stage 
starvation and cancer. In our study, the mean age in the first group (ill for <5 
years) was 50 years, and in the second (5-10 yesrs) and third group (>10 years), it 
was 57 years of age. The findigs of Florakis et al. showed that the cupping and 
atrophy of the optic disc are a consequence of the disease and are not correlated 
with the age of the patients. We found atrophy of the optic disc only in the third 
group. Since there is not much difference between the mean age of the groups, we 
 
Excessive corneal dryness may lead to the appearance of mucous threads attached 
to the cornea, a condition known as filamentary keratitis. Lysosomal enzyme 
elevations versus controls were lower in patients with SS who had filamentary 
keratitis (n = 27) compared with those subjects who did not (n = 11) with the 
exception of AGU, CATH B, and CAH D, which were mildly elevated. 
 The specific enzyme activities and some of the ophthalmologic findings 
depended on the duration of SS, but they were independent on the severity of the 
disease.  
 
5.2. Rheumatoid arthritis (RA) 
 
5.2.1 Ophthalmological signs of patients with RA 
 We found that 16 patients had KCS which is the most frequent 
ophthalmological symptom of RA. Distorsion of the episcleral blood vessels, 
cataract, angiopathy, atrophy of the optic disc and visual defect were found at 5, 9, 
8, 10, and 5 patients, respectively. Keratitis, corneal degeneration, corneal ulcer 
and maculopathy were found at three, while pseudoexfoliation and conjunctival 
degeneration were found at two patients. 
 Keratitis (22%) were more common in the second group (5-10 years), while 
corneal degeneration occurred mainly both in the second (5-10 years) and in the 
third group (>10 years) (10%-10%).  
5.2.2 Lysosomal enzyme activities in leukocytes of patients with RA 
 Significantly increased activities were found in case of AGU, HEX, DPP I, 
CATH B and CATH D calculated with the results of all patients in the three 
groups, while BGA, AMAN, CATH H, DPP II and TPP I did not show any 
significant changes.  
 Significantly decreased lysosomal enzyme activities were found in case of 
BGA in the first group (who were diagnosed with RA less than five years before 
our investigations); but in case of AMAN, GCU, HEX, CATH H, DPP II, and TPP 
I the decrease was not significant. The enhancement in the enzyme activities was 
the highest in the third group (who were sick for more 10 years) with the exception 
of BGA. CATH B showed the greatest enzyme activity increase in all of the 3 
groups of patients. The activities of CATH B were 7 times, 4 times, and 8 times 
higher in the first, second, and third group, respectively than in the control group. 
5.2.3 Association between lysosomal enzyme activities and ophthalmologial signs 
of patients with RA 
 Figure 5 demonstrates the correlation between the presence of keratitis and the 
specific enzyme activities. All of the enzymes showed higher elevation 
while those patients who had any kind of corneal degeneration showed high 
elevation of CATH B.   
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5.3. Systemic lupus erythematosus (SLE) 
 
5.3.1 Ophthalmological signs of patients with SLE  
 We found that 18 patients had KCS, 4 and 5 had corneal- and 
conjunctival degeneration, respectively, 6 had cataract, 10 had angiopathy of the 
fundus, 7 had atrophy of the optic nerve, 4 had visual field defect, and 1 had retinal 
branch artery occlusion.  
 Both optic neuropathy and retinal occlusive disease can result in optic 
atrophy. We investigated the occurance of the optic nerve atrophy in the three 
groups of patients. The number of patients with atrophy of the optic nerve was less 
(30%) in the third group (>10 years) than in the second one (5-10 years) (40%). 
5.3.2 Lysosomal enzyme activities in leukocytes of patients with SLE 
 Significantly increased activities of the glycosidases and proteases were 
found in all SLE patients as compared to the controls with the exception of  CATH 
H. In all of the SLE patients, significantly increased activities of the glycosidases 
(AGU, BGA, AMAN, GCU, HEX), and the proteinases (CATH C, DPP I, TPP I, 
CATH B, CATH D) were found, as compared with controls (p<0.05). In cases of 
AGU and AMAN, the enzyme activities decreased in the second group (SLE was 
diagnosed more than 5, but less than 10 years prior to our investigations), and than 
increased again in the third group (> 10 years). In cases of GCU and HEX, the 
same amount of enzyme level elevation was shown in all three groups. TPP I and 
CATH B had the highest enzyme activities in the first group of patients, who were 
diagnosed less than 5 years before our investigations. BGA, CATH C, DPP I and 
II, and CATH D showed the highest elevation in the second group of SLE patients.  
5.3.3 Association between lysosomal enzyme activities and ophthalmologial signs 
of patients with SLE  
 All of the enzymes showed higher elevation among those patients who 
had optic nerve atrophy, except for CATH H and CATH D.  
 
5.4. Comparison of the results of the three polysystemic autoimmune diseases 
 Significant changes were found in specific lysosomal enzyme activities in 
leukocytes from patients of the three groups of investigated polysytemic 
autoimmune diseases compared to the healthy controls. We found, that in the cases 
of patients with SS, the highest enzyme activity elevations were observed in the 
second period of SS (5-10 years). Whereas, most of the enzyme activities were 
lower in the third group of SS patients (> 10 years) than in the second group.  
 
 
 
 
 
 In occurrence of RA, contrary to the results of SS, the increase in the 
enzyme activities was the highest in the third group (who were sick for more than 
10 years) with the exception of BGA. 
In case of patients with SLE, we found that the activity changes of 
lysosomal enzymes during the progression of the disease showed a high variety. 
Similar pattern in the elevation of activities of BGA, DPP I, and CATH H has been 
observed in the patients with SS.  
 
6. DISCUSSION 
 
6.1 Ophthalmological signs in patients of the three polysystemic autoimmune 
diseases 
Many ophthalmological signs were seen even in the first groups of 
patients diagnosed with SS, RA, or SLE who were sick less than 5 years. Different 
signs were characteristic for the investigated three polysystemic autoimmune 
diseases, except for KCS which was the most frequent ophthalmological symptom 
in each disease. Most of the observed ophthalmological signs differ with the 
duration of the disease. Interestingly, less patients had corneal degeneration, 
cataract, atrophy of the optic nerve, and visual field defects in case of SS and 
atrophy of the optic nerve in case of RA and SLE in the third group (>10 years) 
than in the second one (5-10 years).  
 
6.2 Changes in lysosomal enzyme activities 
 Changes in lysosomal enzyme activities may result in impairment of 
phagocytic and endocytic activities, inadequate extracellular matrix turnover, and 
remodeling, which suggest that lysosomal enzyme activities might be involved in 
the pathogenesis of autoimmune diseases. Therefore, we supposed that activities of 
lysosomal enzymes might also show correlation with ophthalmic signs of the 
disease.  
 We found that acid glycosidases, except for AGU, showed 2- to 3-fold 
higher elevation of activities than that of the control values. These were the 
greatest increases among the lysosomal enzymes mesured in the leukocytes of 
individuals with SS. These enzymes play a role in catabolism of glycoproteins to 
monosaccharides and amino acids. All of the six enzymes studied were extremely 
hyperactivited in subjects with SS of 5-10 years’ duration. We experienced that the 
proteases with the most elevated activities in SS are TPP I and DPP II.  
In cases of RA patients we found that the activities of two lysosomal 
cysteine proteases (CATH B and DPP I), two glycosidases (AGU and HEX), and 
an aspartic protease (CATH D) were elevated, but these elevations can not give   
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